Immuno-Oncology 360

IO360˚convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.

JOIN THE SCB MAILING LIST TO RECEIVE NEWS AND UPDATES

Mailing List

Name

First Name

Last Name

Sector

While you may be affiliated with more than one sector, please select the one that is most closely aligned with your work.

By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.